Jiang et al. genetically modified NK-92MI cells with a CAR containing anti-CD138 fragment, which showed significantly enhanced cytotoxicity toward the CD138-positive multiple myeloma cells compared with the CD138-negative counterparts 106. The gene discussed is SDC1; the disease is AL amyloidosis.